CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY
$0.42
+0.72% today
Updated 2026-04-30
Market cap
$12.38M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$0 – $9
Volume
5.3M
Curanex Pharmaceuticals Inc Common Stock (CURX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $10232.00 | $74366.00 | $517935.00 |
| Cash & equivalents | $2430.00 | $74366.00 | $148891.00 |
| Current assets | $10232.00 | $74366.00 | $517935.00 |
| Total liabilities | $0.00 | $14276.00 | $14575.00 |
| Current liabilities | $0.00 | $14276.00 | $14575.00 |
| Long-term debt | — | — | — |
| Shareholder equity | $10232.00 | $60090.00 | $503360.00 |
| Retained earnings | $-241745.00 | $-260943.00 | $-622449.00 |
| Accounts receivable | — | — | — |
| Inventory | $2987.00 | $0.00 | — |
| Goodwill | — | — | — |